Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903).
Friedlander M, Benson C, O'Connell RL, Reed N, Clamp A, Lord R, Millan D, Nottley S, Amant F, Steer C, Anand A, Mileshkin L, Beale P, Banerjee S, Bradshaw N, Kelly C, Carty K, Divers L, Alexander L, Edmondson R. Friedlander M, et al. Among authors: mileshkin l. Gynecol Oncol. 2021 Apr;161(1):160-165. doi: 10.1016/j.ygyno.2021.02.016. Epub 2021 Feb 16. Gynecol Oncol. 2021. PMID: 33608144 Clinical Trial.
Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.
Obermair A, Mileshkin L, Bolz K, Kondalsamy-Chennakesavan S, Cheuk R, Vasey P, Wyld D, Goh J, Nicklin JL, Perrin LC, Sykes P, Janda M. Obermair A, et al. Among authors: mileshkin l. Gynecol Oncol. 2011 Feb;120(2):179-84. doi: 10.1016/j.ygyno.2010.10.039. Epub 2010 Dec 3. Gynecol Oncol. 2011. PMID: 21126755 Clinical Trial.
Carboplatin dosing in ovarian cancer: problems and pitfalls.
Collins IM, Roberts-Thomson R, Faulkner D, Rischin D, Friedlander M, Mileshkin L. Collins IM, et al. Among authors: mileshkin l. Int J Gynecol Cancer. 2011 Oct;21(7):1213-8. doi: 10.1097/IGC.0b013e31822127ad. Int J Gynecol Cancer. 2011. PMID: 21705909 Review.
Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.
Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J, O'Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian Cancer Patterns of Care Study Group. Jordan S, et al. Gynecol Oncol. 2013 May;129(2):310-7. doi: 10.1016/j.ygyno.2013.02.007. Epub 2013 Feb 9. Gynecol Oncol. 2013. PMID: 23403164 Free article.
Oral cyclophosphamide in recurrent ovarian cancer.
Handolias D, Quinn M, Foo S, Mileshkin L, Grant P, Dutu G, Rischin D. Handolias D, et al. Among authors: mileshkin l. Asia Pac J Clin Oncol. 2016 Mar;12(1):e154-60. doi: 10.1111/ajco.12074. Epub 2013 May 29. Asia Pac J Clin Oncol. 2016. PMID: 23718870
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Stelloo E, Bosse T, Nout RA, MacKay HJ, Church DN, Nijman HW, Leary A, Edmondson RJ, Powell ME, Crosbie EJ, Kitchener HC, Mileshkin L, Pollock PM, Smit VT, Creutzberg CL. Stelloo E, et al. Among authors: mileshkin l. Mod Pathol. 2015 Jun;28(6):836-44. doi: 10.1038/modpathol.2015.43. Epub 2015 Feb 27. Mod Pathol. 2015. PMID: 25720322 Free article.
Geriatric assessment of older patients with cancer in Australia--a multicentre audit.
Lakhanpal R, Yoong J, Joshi S, Yip D, Mileshkin L, Marx GM, Dunlop T, Hovey EJ, Della Fiorentina SA, Venkateswaran L, Tattersall MH, Liew S, Field K, Singhal N, Steer CB. Lakhanpal R, et al. Among authors: mileshkin l. J Geriatr Oncol. 2015 May;6(3):185-93. doi: 10.1016/j.jgo.2015.03.001. Epub 2015 Mar 23. J Geriatr Oncol. 2015. PMID: 25813881
294 results